No dosing, administration, clinical, cosmetic, or human-use guidance
Is subcutaneous or intramuscular injection better for knee injuries
Animal models suggest that BPC 157 may support recovery by influencing tissue repair pathways involved in cellular migration, wound closure, and functional recovery
For the myotendinous junction, as a combination point of anatomical and structural particularities (largely reviewed in [124,125]) such a new therapy possibility might be particularly important given the still unresolved problem of being the weakest element in the muscletendon unit, (and bonetendon junctions as extremely specialized tissues in general)
All three mechanisms operate simultaneously, which is what makes TB-500 effective for the range of applications where it is prescribed